An open-label, crossover, interventional Phase IV study to compare the ease of use of tobramycin inhalation powder with tobramycin inhalation solution and nebulized colistimethate for the treatment of pulmonary Pseudomonas aeruginosa in patients with cyst
Read time: 1 mins
Last updated:16th Apr 2013
To compare the mean cumulative time required to prepare the drug, set-up the delivery device, administer the drug, and clean the delivery device using TIP administered with the T 326 Inhaler with the cumulative time to use the patient�s usual (pre-study prescribed) nebulized, antibiotic treatment for P. aeruginosa, as a primary indicator of ease of use.
|Study start date||2013-04-16|